title: Percutaneous treatment of pyocystis in patients with autosomal dominant polycystic kidney disease.
abstract: The course of autosomal dominant polycystic kidney disease (ADPKD) is frequently complicated by infection of a cyst within a polycystic kidney, which is a diagnostic and therapeutic dilemma damaging the clinical course of patients. The aim of this study was to demonstrate the safety and efficacy of percutaneous drainage in management of infected cysts in ADPKD patients. Between May 2003 and December 2006, percutaneous drainage was performed in 16 infected renal cysts of four kidneys in three patients (two females, one male), with a mean age of 57.3 years. Cyst dimensions, total amount of drained cyst fluid, catheterization duration, isolated microorganisms, and follow-up duration were recorded. Technical, clinical success rates were 100%; the complication rate was 0%. Diameters of cysts ranged between 3 and 8 cm. Average volume of drained fluid and average duration of catheterization for one cyst were 226 ml and 9.8 days. No recurrence was encountered but one patient (no. 3), who had pyocystis in the right kidney and was treated with catheterization, referred with left flank pain due to pyocystis in her left kidney 3 months later. Follow-up durations were 35, 47, and 11 months for patients 1, 2, and 3, respectively. For patient 3, follow-up duration for the second procedure was 7 months. We conclude that percutaneous drainage with antibiotic therapy should be the initial method in management of infected cysts in ADPKD patients, with high success and low complication rates.
authors.affiliation: Department of Radiology, Hacettepe University School of Medicine, Sihhiye, 06100, Ankara, Turkey. akincid@yahoo.com
authors.forename: Devrim
authors.initials: D
authors.lastname: Akinci
authors.forename: Baris
authors.initials: B
authors.lastname: Turkbey
authors.forename: Rahmi
authors.initials: R
authors.lastname: Yilmaz
authors.forename: Erhan
authors.initials: E
authors.lastname: Akpinar
authors.forename: Mustafa N
authors.initials: MN
authors.lastname: Ozmen
authors.forename: Okan
authors.initials: O
authors.lastname: Akhan
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002406:Catheterization, Peripheral / Q000379:methods; D003556:Cystitis / Q000150:complications* / Q000000981:diagnostic imaging / Q000628:therapy*; D003560:Cysts / Q000150:complications / Q000000981:diagnostic imaging / Q000382:microbiology / Q000628:therapy*; D004322:Drainage / Q000009:adverse effects / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007668:Kidney / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D016891:Polycystic Kidney, Autosomal Dominant / Q000150:complications* / Q000175:diagnosis*; D015641:Radiography, Interventional; D012189:Retrospective Studies; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D018608:Ultrasonography, Doppler
chemical_list: D000900:Anti-Bacterial Agents